ENTITY
Neuren Pharmaceuticals

Neuren Pharmaceuticals (NEU AU)

38
Analysis
Health CareAustralia
Neuren Pharmaceuticals Ltd. is a biopharmaceutical company. The Company researches neurological and metabolic disorders.
more
Refresh
04 Sep 2022 22:04

S&P ASX Sep 22 Rebal: Decent Impacts but Avoid Short Buildup

The Top 10 ADDs & DELs have average impacts of +12.7 and -11.2 days to trade respectively. Some DELs names have significant short buildup.

Share
03 Sep 2022 07:01

S&P/​​ASX Index Rebalance (Sep 2022): Adds, Deletes, Surprises & Pre-Positioning

There are a lot of changes to the ASX200 and ASX300 indices with high impact. There are a few surprises, mainly in the ASX300. Shorts have surged...

Logo
537 Views
Share
05 Dec 2017 14:26

Aussie Healthcare Daily: 5 Dec 2017

The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...

Logo
146 Views
Share
bearishMacroeconomics
01 Apr 2015 11:31

Taxing Times For Australia

The Government's release of Re:think, its tax discussion paper, is a welcome development, designed to kick-start the conversation with the...

Logo
5.7k Views
Share
x